Cargando…
Management and Medical Therapy of Mild Hypercortisolism
Mild hypercortisolism (mHC) is defined as an excessive cortisol secretion, without the classical manifestations of clinically overt Cushing’s syndrome. This condition increases the risk of bone fragility, neuropsychological alterations, hypertension, diabetes, cardiovascular events and mortality. At...
Autores principales: | Favero, Vittoria, Cremaschi, Arianna, Falchetti, Alberto, Gaudio, Agostino, Gennari, Luigi, Scillitani, Alfredo, Vescini, Fabio, Morelli, Valentina, Aresta, Carmen, Chiodini, Iacopo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584167/ https://www.ncbi.nlm.nih.gov/pubmed/34768949 http://dx.doi.org/10.3390/ijms222111521 |
Ejemplares similares
-
Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside
por: Favero, Vittoria, et al.
Publicado: (2022) -
SUN-614 Prediction of Hypertension, Diabetes and Fractures in Eucortisolemic Women by Measuring Parameters of Cortisol Milieu
por: Chiodini, Iacopo, et al.
Publicado: (2020) -
Defining Nonfunctioning Adrenal Adenomas on the Basis of the Occurrence of Hypocortisolism after Adrenalectomy
por: Eller-Vainicher, Cristina, et al.
Publicado: (2020) -
Energy Metabolism and Ketogenic Diets: What about the Skeletal Health? A Narrative Review and a Prospective Vision for Planning Clinical Trials on this Issue
por: Merlotti, Daniela, et al.
Publicado: (2021) -
Management of Osteoporosis in Men: A Narrative Review
por: Vescini, Fabio, et al.
Publicado: (2021)